Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mochi Health at a glance Mochi Health pairs telehealth with insurance-navigation support, positioning coverage assistance as part of the service
Transition planning A cold-turkey stop from tirzepatide can cause rebound appetite and rapid weight regain
Evening application after washing is ideal your scalp is clean and you won't be sweating or washing for hours
Subcutaneous injections carry a small but non-zero bleeding risk for patients on warfarin, heparin, or direct oral anticoagulants
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management as Zepbound
While a generic small-molecule drug might cost 80 to 90% less than the brand-name, biosimilars typically cost only 15 to 35% less
US$ 22.22
US$ 21.13
US$ 28.10
US$ 27.60
US$ 22.52
US$ 21.07
US$ 23.71
US$ 20.92
